United States· US:81683-025_323956e6-36bd-5542-e063-6294a90acd17
RockSauce FIERY HOT PAIN RELIEF
A medicinal product containing menthol; capsaicin; methyl salicylate, registered in United States by Implus Footcare, LLC.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- MENTHOL; CAPSAICIN; METHYL SALICYLATE
- Manufacturer
- Implus Footcare, LLC
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1181683025012.45 mL in 1 POUCH (81683-025-01)
- ndc1181683-025-01
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e055e16b-147d-41a3-aac9-e620c3fc19bd GET /v1/drugs/e055e16b-147d-41a3-aac9-e620c3fc19bd?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "TOPICAL",
"source": "ndc",
"strength": ".25; .00005; .5",
"substance": "MENTHOL; CAPSAICIN; METHYL SALICYLATE",
"productndc": "81683-025",
"dosage_form": "CREAM",
"dea_schedule": null,
"strength_unit": "g/2.45mL; g/2.45mL; g/2.45mL",
"application_number": "M017",
"marketing_category": "OTC MONOGRAPH DRUG"
}See everything about menthol; capsaicin; methyl salicylate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.